1 active not recruiting, 1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Metastatic Rectal Carcinoma: new trials by email Literature Review of Metastatic Rectal Carcinoma trials Research Report on Metastatic Rectal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| xDRIVE in Metastatic Colorectal Cancer Functional precision medicine - Metastatic Colon Adenocarcinoma, Metastatic Colon Cancer | Withdrawn | First Ascent Biomedical Inc. | 2025-09-15 | 2026-09-02 | ||
| Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events Best Practice, Patient Monitoring, Questionnaire Administration - Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 750 | 2021-05-12 | 2026-06-16 |
| Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery Laboratory Biomarker Analysis, Trametinib, Trifluridine and Tipiracil Hydrochloride - Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma | Phase 1 | Completed | City of Hope Medical Center | 26 | 2018-04-11 | 2024-04-08 |
Colonic Neoplasms (3) · Rectal Neoplasms (3) · Colorectal Neoplasms (2) · Carcinoma, Hepatocellular (1) · Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3) · Gastrointestinal Neoplasms (2) · Adenocarcinoma (1) · Carcinoma (1) · Colorectal Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Practice Guidelines as Topic (1) · Remote Patient Monitoring (1) · Standard of Care (1) · Trifluridine (1) · trametinib (1) · trifluridine tipiracil drug combination (1)
City of Hope Medical Center (1) · First Ascent Biomedical Inc. (1) · M.D. Anderson Cancer Center (1)
United States (2)
Diana J Azzam, PhD (1) · Hao Xie, MD PhD (1) · Lisa Boardman, MD (1) · Marwan G Fakih (1) · Noah Berlow, PhD (1) · Ryan W Huey, MD (1)
P30CA033572 (1)